C12N 2533/90
Substrates of biological origin
Official title: Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
C12N2533/90 (Substrates of biological origin) appears on 811 US grants and 1,927 published applications in this corpus.
Search patents in C12N- Granted patents
- 811
- Published applications
- 1,927
- Assignees
- 808
- Inventors
- 3,642
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 5 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 7 | 5 |
| 2002 | 12 | 28 |
| 2003 | 7 | 20 |
| 2004 | 5 | 22 |
| 2005 | 5 | 38 |
| 2006 | 8 | 14 |
| 2007 | 10 | 31 |
| 2008 | 10 | 30 |
| 2009 | 11 | 28 |
| 2010 | 10 | 52 |
| 2011 | 16 | 37 |
| 2012 | 19 | 48 |
| 2013 | 16 | 46 |
| 2014 | 32 | 61 |
| 2015 | 40 | 65 |
| 2016 | 23 | 60 |
| 2017 | 51 | 81 |
| 2018 | 29 | 93 |
| 2019 | 51 | 130 |
| 2020 | 49 | 119 |
| 2021 | 47 | 121 |
| 2022 | 60 | 175 |
| 2023 | 63 | 173 |
| 2024 | 74 | 170 |
| 2025 | 80 | 162 |
| 2026 | 51 | 118 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Complex microfluidic models for ALS including NF biomarkers for ALS research and drug development29 Sep 2026US 12,748,102 B2Cedars-Sinai Medical Center
- Avian enteroids22 Sep 2026US 12,742,155 B2The University Court of the University of Edinburgh
- Method for the in vitro or ex vivo amplification of human adipose tissue stem cells1 Sep 2026US 12,723,234 B2Centre National de la Recherche Scientifique (CNRS)
- Method of in vitro chondrocyte and cartilage culture to obtain material for the treatment of articular cartilage defects25 Aug 2026US 12,714,766 B2Arthec S.A.
- Hybrid-hydrogels comprising decellularized extracellular matrix25 Aug 2026US 12,714,767 B2The Regents of the University of Colorado, a body corporate
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- 3d epithelial organoid culture systems and methods1 Oct 2026US 2026/0297486 A1The Regents of the University of California
- Composition1 Oct 2026US 2026/0297507 A1
- Cells, islets, and organoids that evade immune detection and autoimmunity, methods of production and use thereof1 Oct 2026US 2026/0297530 A1The Salk Institute for Biological Studies
- Cancer models1 Oct 2026US 2026/0297534 A1Carcinotech Ltd
Most cited
By later US patents
- Urinary bladder submucosa derived tissue graft433US 5,554,389 APurdue Research Foundation · 1996
- Simultaneous stimulation and concentration of cells422US 6,797,514 B2XCYTE Therapies, Inc. · 2004
- Simultaneous stimulation and concentration of cells398US 6,867,041 B2XCYTE Therapies, Inc. · 2005
- Simultaneous stimulation and concentration of cells383US 6,905,874 B2XCYTE Therapies, Inc. · 2005
- Repair of cartilage and bones372US 4,642,120 ARamot University Authority for Applied Research and Industrial Development Ltd. · 1987